GlassScriptPhysician profile
Mohd A Hossain
NPI 1083931919
$1,585.46
in general payments reported to CMS, 2019-2025
19 companies · $576 in 2025
The $576 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.96 · 2020: $21.77 · 2021: $79.62 · 2022: $137 · 2023: $291 · 2024: $461 · 2025: $576.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,328.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $221.35 | 2024-2025 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $207.03 | 2022-2024 | |
| Abbott Laboratories | $156.95 | 2023-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $153.43 | 2021-2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $148.23 | 2023-2024 | Cologuard Collection Kit |
| Shield Therapeutics INC | $113.33 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $94.34 | 2022-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $87.15 | 2024-2025 | |
| Glaxosmithkline, LLC. | $69.35 | 2022-2025 | Trelegy Ellipta |
| Redhill Biopharma INC. | $54.71 | 2020-2022 | |
| Mannkind Corporation | $50.01 | 2025 | |
| Novo Nordisk INC | $43.74 | 2025 | Ozempic, Rybelsus |
| Idorsia Pharmaceuticals US INC | $40.96 | 2023 | Quviviq |
| Amgen INC. | $40.01 | 2025 | Repatha, Otezla |
| Averitas Pharma INC. | $29.81 | 2024 | Qutenza |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $26.76 | 2023 | Rexulti |
| Janssen Pharmaceuticals, INC | $17.96 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.84 | 2022 | |
| Treace Medical Concepts, INC. | $13.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohd Hossain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.